These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11980090)

  • 1. Transduction efficiency of adenoviral vectors into human glioma cells increased by association with cationic liposomes.
    Ryuke Y; Mizuno M; Natsume A; Yoshida J
    Neurol Med Chir (Tokyo); 2000 May; 40(5):256-60. PubMed ID: 11980090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell lines.
    Fukuhara H; Hayashi Y; Yamamoto N; Fukui T; Nishikawa M; Mitsudo K; Tohnai I; Ueda M; Mizuno M; Yoshida J
    Oral Oncol; 2003 Sep; 39(6):601-9. PubMed ID: 12798404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
    Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
    Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells.
    Viola JJ; Ram Z; Walbridge S; Oshiro EM; Trapnell B; Tao-Cheng JH; Oldfield EH
    J Neurosurg; 1995 Jan; 82(1):70-6. PubMed ID: 7815137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced transduction efficiency of adenoviral vectors expressing human p53 gene by repeated transduction into glioma cells in vitro.
    Yamamoto S; Yoshida Y; Aoyagi M; Ohno K; Hirakawa K; Hamada H
    Clin Cancer Res; 2002 Mar; 8(3):913-21. PubMed ID: 11895926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of adenoviral transduction with polycationic liposomes in vivo.
    Lee SG; Yoon SJ; Kim CD; Kim K; Lim DS; Yeom YI; Sung MW; Heo DS; Kim NK
    Cancer Gene Ther; 2000 Oct; 7(10):1329-35. PubMed ID: 11059690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
    Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
    Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
    Meeker TC; Lay LT; Wroblewski JM; Turturro F; Li Z; Seth P
    Clin Cancer Res; 1997 Mar; 3(3):357-64. PubMed ID: 9815692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE.
    Steel JC; Cavanagh HM; Burton MA; Abu-Asab MS; Tsokos M; Morris JC; Kalle WH
    Eur J Pharm Sci; 2007 Apr; 30(5):398-405. PubMed ID: 17275269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
    Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene.
    Verwijnen SM; Sillevis Smith PA; Hoeben RC; Rabelink MJ; Wiebe L; Curiel DT; Hemminki A; Krenning EP; de Jong M
    Cancer Biother Radiopharm; 2004 Feb; 19(1):111-20. PubMed ID: 15068619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of oocytes and other types of ovarian cells in rabbits after direct injection into uterine arteries of adenoviruses and plasmid/liposomes.
    Laurema A; Heikkilä A; Keski-Nisula L; Heikura T; Lehtolainen P; Manninen H; Tuomisto TT; Heinonen S; Ylä-Herttuala S
    Gene Ther; 2003 Apr; 10(7):580-4. PubMed ID: 12646863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.